CARE Ratings Ltd (CARERATING) Announcements - Latest Exchange Filings with AI Summaries
Latest corporate announcements filed by CARE Ratings Ltd on NSE and BSE, with an AI summary of each filing.
Allotment of 16,133 equity shares pursuant to exercise of ESOP
Others (Uncategorized) · 03 Nov 2026, 10:13 pm
CARE Ratings Approves ESOP Allotment of 16,133 Equity Shares CARE Ratings Limited's Nomination and Remuneration Committee approved the allotment of 16,133 equity shares of face value Rs. 10 each on 3rd Nov'26 pursuant to the exercise of options under the CARE Employee Stock Option Scheme 2020. Consequently, the company's paid-up equity share capital increases from Rs. 30,13,26,120 (3,01,32,612 equity shares) to Rs. 30,14,87,450 (3,01,48,745 equity shares).
Intimation of Investor Meet
Intimation · 31 Oct 2026, 12:11 am
CARE Ratings Schedules In-Person Investor Meeting with EM Capital Advisors CARE Ratings Limited has scheduled an in-person meeting with institutional investor EM Capital Advisors on 5th Nov'26 at 03:00 PM, pursuant to Regulation 30 of SEBI (LODR) Regulations, 2015. The discussions will rely strictly on publicly available information, and the company has referenced its Q2FY27 investor presentation available on its official website.
Investor Presentation
Investor Presentation · 30 Oct 2026, 2:24 am
CARE Ratings Q2 FY27 Consolidated Net Profit Rises 26% YoY to Rs 72.37 Crore CARE Ratings reported strong Q2 FY27 financial results, with consolidated operating income rising 20% YoY to Rs 164.13 crore. EBITDA grew 23% YoY to Rs 84.61 crore with a 52% margin, while PAT expanded 26% YoY to Rs 72.37 crore (40% margin), delivering an EPS of Rs 23.88. Segmentally, ratings revenue rose 21% YoY to Rs 148.51 crore, and non-ratings revenue grew 15% YoY to Rs 15.62 crore. The board declared an interim dividend of Rs 10 per share for Q2 FY27.
Press Release
Press Release · 30 Oct 2026, 2:22 am
CARE Ratings Reports Strong Q2 FY27 Results with 26% Consolidated PAT Growth CARE Ratings reported a strong financial performance for Q2 FY27, with consolidated operating income rising 20% YoY to Rs 164.13 Crs, driven by a 21% YoY growth in ratings business (Rs 148.51 Crs) and 15% in non-ratings (Rs 15.62 Crs). Consolidated EBITDA increased 23% YoY to Rs 84.61 Crs with a 52% margin, while PAT rose 26% YoY to Rs 72.37 Crs at a 40% margin, delivering an EPS of Rs 23.88. The Board also approved an interim dividend of Rs 10 per share.
The Board has approved payment of Interim Dividend of Rs. 10 per equity share
Dividend · 30 Oct 2026, 2:20 am
CARE Ratings Q2 FY27 Results: PAT Up 26.5% YoY, Declares Rs. 10 Dividend CARE Ratings reported a consolidated revenue from operations of Rs. 164.13 crore for the quarter ended 30th Sep'26, up 20.4% YoY from Rs. 136.37 crore (and up 47.0% QoQ). Consolidated net profit grew 26.5% YoY to Rs. 72.37 crore versus Rs. 57.21 crore in Q2 FY26. The Board declared an interim dividend of Rs. 10 per share (record date 6th Nov'26) and appointed Jatindar Pal Singh Bajaj as Non-Executive Non-Independent Director effective 29th Oct'26.
The Board has decided the record date as Friday, November 6, 2026 for payment of interim dividend
Dividend · 30 Oct 2026, 2:18 am
CARE Ratings Reports Strong Q2 FY27 Results and Declares ₹10 Interim Dividend CARE Ratings approved Q2 FY27 financial results, reporting consolidated revenue from operations of ₹164.13 crore (up 20.36% YoY) and net profit attributable to owners of ₹71.85 crore (up 26.79% YoY). The Board declared an interim dividend of ₹10 per equity share for FY27, setting the record date as 6th Nov'26. Additionally, the Board appointed Mr. Jatindar Pal Singh Bajaj as an Additional Non-Executive Non-Independent Director effective 29th Oct'26, and noted agreements to sell a combined 19.80% stake in subsidiary CareEdge Global IFSC.
Appointment of Additional Director in the category of Non-Executive Non-Independent Director
Change in Management · 30 Oct 2026, 2:15 am
CARE Ratings Q2 FY26–27 Consolidated PAT Up 26.5% YoY; Interim Dividend Declared CARE Ratings reported a consolidated revenue from operations of Rs. 164.13 cr for the quarter ended 30th Sep'26, rising 20.4% YoY from Rs. 136.37 cr. Net profit rose 26.5% YoY to Rs. 72.37 cr, with profit attributable to owners reaching Rs. 71.85 cr. The Board approved an interim dividend of Rs. 10 per share (face value Rs. 10) with the record date set for 6th Nov'26. Additionally, the Board appointed Mr. Jatindar Pal Singh Bajaj as Non-Executive Non-Independent Additional Director effective 29th Oct'26.
Outcome of the Board meeting
Financial Result · 30 Oct 2026, 2:00 am
Outcome of the Board Meeting
Outcome · 30 Oct 2026, 1:38 am
CARE Ratings Limited has submitted to the Exchange, the financial results for the period ended September 30, 2026.
Outcome · 30 Oct 2026, 1:36 am
CARE Ratings Q2 FY26-27 Results: PAT Rises 26.5% YoY, Declares ₹10 Interim Dividend CARE Ratings reported a 26.50% YoY increase in consolidated net profit to ₹7,236.70 lakhs for Q2 ended 30th Sep'26, up from ₹5,720.99 lakhs in Q2 FY25-26, driven by a 20.36% YoY growth in revenue from operations to ₹16,413.34 lakhs. Sequentially, revenue surged 46.97% QoQ and net profit rose 119.34% QoQ. The Board declared an interim dividend of ₹10 per share (record date: 6th Nov'26). Additionally, the company agreed to sell a 9.90% stake each in CareEdge Global IFSC to SBI and NSE IFSC.
Update on sale of partial stake held by the Company in its wholly owned subsidiary i.e. CareEdge Global IFSC Limited to State Bank of India and NSE IFSC Limited
Others (Uncategorized) · 19 Oct 2026, 7:53 pm
CARE Ratings Executes Stake Sale in CareEdge Global IFSC to SBI and NSEIX CARE Ratings executed Share Purchase and Shareholders' Agreements on 19th Oct'26 to sell a 9.90% equity stake each in its wholly owned subsidiary, CareEdge Global IFSC Limited (CGIL), to State Bank of India and NSE IFSC Limited. Following closing conditions and CGIL board approval, CGIL will cease to be a wholly owned subsidiary, with CARE Ratings retaining an 80.20% equity stake. The transaction is expected to close within two months.
CARE Ratings Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 29/10/2026 ,inter alia, to consider and approve the Unaudited (Standalone & Consolidated) ....
Intimation · 29 Oct 2026, 5:30 am
CARE Ratings Board to Consider Q2 Results and Interim Dividend on Oct'26 CARE Ratings Limited's Board of Directors will meet on 29th Oct'26 to consider and approve the standalone and consolidated unaudited financial results for the quarter and half-year ended 30th Sep'26. The board will also consider the declaration of an interim dividend for FY27. Consequently, the trading window for dealing in company shares, closed since 1st Oct'26, will remain shut until 48 hours post the financial results announcement.
CARE Ratings Limited has informed the Exchange about Board Meeting to be held on 29-Oct-2026 to consider and approve the Half Yearly Unaudited Financial results of the Company for the period ended September 2026 and Dividend.
Intimation · 29 Oct 2026, 5:30 am
To consider and approve the Unaudited (Standalone & Consolidated) Financial Results of the Company for the quarter and half year ended September 30, 2026 and consider declaration of Interim Dividend, if any, for the financial year 2026-27
Intimation · 29 Oct 2026, 5:30 am
Allotment of 14,200 Equity shares pursuant to exercise of ESOP
Others (Uncategorized) · 05 Oct 2026, 10:16 pm
CARE Ratings Approves Allotment of 14,200 Equity Shares Under ESOP Scheme The Nomination and Remuneration Committee of CARE Ratings approved the allotment of 14,200 fully paid-up equity shares of face value Rs.10 each on 5th Oct'26 under the CARE Employee Stock Option Scheme 2020. Consequently, the company's paid-up share capital increased from Rs.30,11,84,120 comprising 3,01,18,412 equity shares to Rs.30,13,26,120 comprising 3,01,32,612 equity shares of Rs.10 each.
Intimation of Investor Meet
Intimation · 24 Sept 2026, 6:29 pm
CARE Ratings Schedules In-Person Institutional Investor Meeting with Nippon India Mutual Fund CARE Ratings Limited has scheduled an in-person analyst/institutional investor meeting with Nippon India Mutual Fund on 30th Sep'26 at 04:00 PM. The interactions will be based strictly on publicly available information, with the company's latest investor presentation already accessible on its official website.
Intimation of Investor Meet
Intimation · 21 Sept 2026, 10:46 pm
CARE Ratings Schedules Investor Meeting with RatnaTraya Capital CARE Ratings Limited has scheduled a virtual analyst/institutional investor meeting with RatnaTraya Capital on 25th Sep'26 at 12:30 PM. The interaction will focus strictly on publicly available information, with the company's latest investor presentation already accessible on its website.
Intimation of Investor Meet
Intimation · 15 Sept 2026, 5:18 pm
CARE Ratings Schedules In-Person Institutional Investor Meetings for 21st Sep'26 CARE Ratings Limited announced its schedule for in-person Analyst and Institutional Investor meetings on 21st Sep'26. The company will host Quest Investment Managers at 2:30 PM and Bandhan Mutual Fund at 4:30 PM. All discussions will rely strictly on publicly available information, with the investor presentation accessible on the company's website.
Intimation of Investor Meet
Intimation · 04 Sept 2026, 5:55 pm
Intimation of Cancellation of Investor Meet
Intimation · 03 Sept 2026, 9:52 pm
CARE Ratings Cancels Scheduled Analyst and Institutional Investor Meet CARE Ratings Limited cancelled its analyst and institutional investor meeting scheduled for 3rd Sep'26 at 8:00 PM IST. The event, initially announced on 20th Aug'26, was called off due to unspecified exigencies. The corporate disclosure was filed pursuant to SEBI Regulation 30 listing obligations.
Allotment of 24,500 equity shares pursuant to exercise of ESOP
Others (Uncategorized) · 02 Sept 2026, 9:49 pm
CARE Ratings Allots 24,500 Equity Shares Under 2020 ESOP Scheme On 2nd Sep'26, CARE Ratings approved the allotment of 24,500 fully paid-up equity shares of Rs.10 face value following the exercise of options under the CARE Employee Stock Option Scheme 2020. Consequently, the company's total paid-up share capital increases from Rs. 30,09,39,120 (3,00,93,912 shares) to Rs. 30,11,84,120 (3,01,18,412 shares). This routine ESOP allotment results in a marginal expansion of the outstanding equity base.
Intimation of Investor Meet
Intimation · 01 Sept 2026, 11:00 pm
CARE Ratings Schedules Investor Meet with SteadFort Investment Managers CARE Ratings Limited (CARERATING) has scheduled an in-person analyst meeting with SteadFort Investment Managers on 10th Sep'26 at 12:30 PM. The company, which trades under scrip codes 534804 on BSE and CARERATING on NSE, has indicated that discussions will be based on publicly available information. An investor presentation is already accessible on the company's website. The meeting schedule is subject to change based on exigencies.
Intimation of Investor Meet
Intimation · 27 Aug 2026, 10:24 pm
CARE Ratings Schedules In-Person Meeting with Artisan Partners CARE Ratings Ltd. has scheduled an in-person meeting with Artisan Partners on 10th Sep'26 at 02:30 PM. The company stated that discussions will be based on publicly available information, with the investor presentation already available on the company's website. The meeting schedule is subject to potential changes.
Intimation of Reschedule of Investor Meet
Intimation · 20 Aug 2026, 11:26 pm
CARE Ratings Reschedules Investor Meeting with Oyster Rock Capital CARE Ratings announced a change to its scheduled Investor/Analyst meeting with Oyster Rock Capital. The meeting, originally set for 3:15 PM IST on 26th Aug'26, has been rescheduled to 5:15 PM IST on the same day due to undisclosed exigencies. The company confirmed that discussions will be based on publicly available information, with no unpublished price-sensitive information (UPSI) to be shared. An investor presentation is already available on the company's website.
Intimation of Investor Meet
Intimation · 20 Aug 2026, 11:17 pm
CARE Ratings Schedules Virtual Investor Meet with TenCore Partners CARE Ratings (CARERATING) has scheduled a virtual analyst and institutional investor meeting with TenCore Partners for 3rd Sep'26 at 8:00 PM. Per the 20th Aug'26 filing, discussions will be based on publicly available information, and the schedule is subject to change. The company has directed investors to its latest presentation available on its website.